Renovos, a pioneering biotechnology company, proudly announces its recent achievement of Breakthrough Device Designation from the US Food and Drug Administration (FDA) for its groundbreaking product, ...Read More
In 2022, the global orthopedic bone graft substitutes (BGS) market was valued at approximately $2 billion. Compared to 2022, the market was valued at slightly under $2 billion in 2021 because of COVID...Read More
Infuse bone graft (Medtronic) Within the U.S. Orthopedic Biomaterials market, multiple segments are discussed including bone graft substitutes, cellular allografts, and growth factors. Bone graft subs...Read More
Register to receive a free U.S. Market Report Suite for Orthopedic Biomaterials report synopsis and brochure Bone infections are notoriously tricky to treat, and antibiotics are frequently prescribe...Read More